Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |